Disclosure Of Entity's Operating Segments [Text Block]

Captor Therapeutics S.A. - Filing #6226332

Concept 2021-01-01 to
2021-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
1 167 910 PLN
124 909 869 PLN
Depreciation and amortisation expense
299 817 PLN
218 366 PLN
Tax expense (income)
0 PLN
5 691 500 PLN
Profit (loss) before tax
13 636 319 PLN
73 654 132 PLN
Profit (loss) from continuing operations
13 636 319 PLN
67 962 632 PLN
Profit (loss)
0 PLN
0 PLN
0 PLN
0 PLN
13 636 319 PLN
13 636 319 PLN
13 636 319 PLN
67 962 632 PLN
67 962 632 PLN
0 PLN
0 PLN
0 PLN
67 962 632 PLN
0 PLN
Assets
151 590 713 PLN
157 187 479 PLN
Liabilities
10 447 179 PLN
10 094 813 PLN
Cash flows from (used in) operating activities
13 496 417 PLN
57 435 477 PLN
Cash flows from (used in) investing activities
18 823 380 PLN
8 579 410 PLN
Cash flows from (used in) financing activities
13 856 788 PLN
20 448 366 PLN
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.